Kura Oncology

Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers. The Company's lead product candidate, tipifarnib, is a potent, selective and orally bioavailable inhibitor of farnesyl transferase. Tipifarnib is a new chemical entity, or NCE, and a member of a class of product candidates called farnesyl transferase inhibitors, or FTIs. Protein farnesylation is a key cell signaling process implicated in various cancer processes, including survival, growth and proliferation of tumor cells. 

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
2007
Size (employees)
30 (est)+12%
Kura Oncology was founded in 2007 and is headquartered in San Diego, US

Kura Oncology Office Locations

Kura Oncology has an office in San Diego
San Diego, US (HQ)
125 11119 N Torrey Pines Rd

Kura Oncology Data and Metrics

Kura Oncology Financial Metrics

USD

Net income (Q1, 2017)

(7.5 m)

Market capitalization (15-Sep-2017)

256.3 m

Cash (31-Dec-2016)

9.7 m
Kura Oncology's current market capitalization is $256.3 m.
USDFY, 2016

Net Income

(27.6 m)
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

R&D expense

3.3 m3 k3.6 m4 m4.3 m5.2 m

General and administrative expense

1.5 m63 k2.4 m1.8 m1.7 m2.1 m

Operating expense total

4.8 m66 k5.9 m5.8 m6 m7.3 m

Interest expense

42 k42 k42 k189 k194 k203 k
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

6.6 k5.6 k15.4 m9.7 m

Accounts Receivable

92.4 m

Inventories

693 k725 k

Current Assets

86.9 m68.8 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.6 k)(30.7 k)(3.7 m)(27.6 m)

Depreciation and Amortization

1 k31 k

Inventories

(42 k)(32 k)

Accounts Payable

(1.5 k)2.1 k833 k471 k
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(5.6 m)(66 k)(6.6 m)(6.7 m)(6.9 m)(7.5 m)

Accounts Payable

8.2 k10.7 k2.5 m3.7 m3.1 m3.3 m4.2 m3.7 m
Show all financial metrics

Kura Oncology Operating Metrics

FY, 2016

Phase II Trials

1

Phase Preclinical

2
Show all operating metrics

Kura Oncology Market Value History

Traffic Overview of Kura Oncology

Kura Oncology Company Life and Culture

You may also be interested in